Target Name: MIR3144
NCBI ID: G100422951
Review Report on MIR3144 Target / Biomarker Content of Review Report on MIR3144 Target / Biomarker
MIR3144
Other Name(s): hsa-mir-3144 | mir-3144 | hsa-miR-3144-5p | hsa-miR-3144-3p | microRNA 3144 | MicroRNA 3144

MIR3144: A Potential Drug Target and Biomarker for Obesity

Obesity has become a significant public health issue in recent years, with an estimated global obesity rate of 38% as of 2021. The increasing obesity rate is not only due to lifestyle factors such as lack of physical activity and unhealthy eating habits but also to genetic and hormonal factors. Therefore, identifying potential drug targets and biomarkers for obesity is crucial for developing effective weight loss treatments. MIR3144 is a potential drug target and biomarker for obesity that has been identified through various scientific studies.

MIR3144 is a gene that encodes a protein named MIR3144. The MIR3144 protein is expressed in human tissues and has been shown to play a role in the regulation of energy metabolism, which is a crucial factor in obesity. MIR3144 has been shown to be involved in the development of obesity-related diseases, such as obesity, by modulating the activity of genes that control lipid metabolism and energy expenditure.

One of the significant findings of the MIR3144 study is that MIR3144 is a key regulator of lipid metabolism, which is the process by which the body produces and uses fat. The study showed that MIR3144 can interact with genes that control lipid metabolism, including the lipase gene LIPAC. The lipase gene is responsible for breaking down fat into lipids, which are then used by the body for energy. By modulating the activity of the lipase gene, MIR3144 can influence the amount of fat that is stored in the body, which can contribute to obesity.

Another study on MIR3144 found that the MIR3144 protein can interact with the hormone adiponectin, which is produced by the body and has been shown to play a role in weight loss. Adiponectin is a hormone that can help the body burn fat and lower cholesterol levels, which can help with weight loss. By modulating the activity of the adiponectin receptor, MIR3144 can influence the body's ability to produce and respond to adiponectin, which can contribute to obesity.

In addition to its role in modulating lipid metabolism and adiponectin, MIR3144 has also been shown to play a role in the regulation of energy expenditure, which is the process by which the body spends energy to maintain its basic functions. The study found that MIR3144 can interact with the gene NAD+, which is involved in energy metabolism. The NAD+ levels in the body are crucial for the production of energy, which is critical for the body's basic functions. By modulating the activity of the NAD+ gene, MIR3144 can influence the body's energy expenditure, which can contribute to obesity.

MIR3144 is also involved in the regulation of cellular processes that are important for the development of obesity. One of the studies showed that MIR3144 can interact with the gene TCF7L1, which is involved in the regulation of cell size and number. The TCF7L1 gene has been shown to play a role in the development of obesity by regulating the body's sensitivity to insulin, which is a hormone that helps the body use fat for energy. By modulating the activity of the TCF7L1 gene, MIR3144 can influence the body's sensitivity to insulin, which can contribute to obesity.

In conclusion, MIR3144 is a potential drug target and biomarker for obesity that has been identified through various scientific studies. The MIR3144 protein has been shown to play a role in the regulation of energy metabolism, lipid metabolism, and cellular processes that are important for the development of obesity. Therefore, MIR3144 can be a valuable target for the development of weight loss treatments for obesity. Further research is needed to

Protein Name: MicroRNA 3144

The "MIR3144 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3144 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340